Assertio (NasdaqCM:ASRT) Q4 2025 Earnings call March 16, 2026 04:30 PM ET Speaker4Ladies and gentlemen, thank you for standing by. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Assertio Holdings Fourth Quarter and Full Year 2025 Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during th ...

Rhythm Pharmaceuticals (NasdaqGM:RYTM) Update / briefing March 16, 2026 04:30 PM ET Company ParticipantsCorinne Johnson - VP of Equity ResearchDave Connolly - Head of Investor RelationsDavid Meeker - Chairman, President, and CEOLisa Walter - VP Biotech Equity ResearchTazeen Ahmad - Managing Director of US Equity ResearchNone - Company RepresentativeConference Call ParticipantsDerek Archila - Equity AnalystEvan Lang - AnalystJon Wolleben - Managing Director and Senior Equity Research AnalystPhil Nadeau - Man ...

Financial Data and Key Metrics Changes - The company generated sales of $515 million for 2025, a decrease of 6% compared to $547 million in the prior year, slightly below the target range of $520 million-$535 million [16] - Adjusted EBITDA for 2025 was $39.2 million, slightly better than the previous year's $39.1 million, but below the target of $40-$44 million [8][17] - Gross profit margin increased to 29% in 2025, while operating expenses as a percentage of sales slightly decreased to 27% [17] Business Line Data and Key Metrics Changes - U.S. crop business sales were similar to the previous year, with improvements in herbicide sales, particularly for the Xelo product [16][25] - Specialty sales improved by 10%, driven by a joint development agreement and growth in mosquito vector solutions [17] - International operations saw a 14% decline in sales due to elevated channel inventories in Mexico and drought conditions in Australia [16] Market Data and Key Metrics Changes - The agricultural sector has not yet recovered from a downturn that began in 2023, with commodity prices remaining below historically normal levels [12] - Farmers are making more last-minute crop decisions, influenced by geopolitical issues, with a forecasted slight decrease in cotton and corn acreage, while soybean acreage is expected to increase [12] Company Strategy and Development Direction - The company is focused on improving its capital structure to pay down expiring credit facilities while maintaining financial flexibility for growth [4] - Plans include rationalizing the Los Angeles manufacturing facility, which is expected to save at least $4 million annually, and relocating the global headquarters to a more cost-effective space, saving approximately $500,000 annually [6][7] - The company aims to launch five new products in North America in 2026 and register at least 25 new products by 2031, with expectations of generating an additional $100 million in annual revenue from new products [10][11] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about future performance, projecting adjusted EBITDA of $44 million-$48 million in 2026 on sales of $530 million-$550 million [14] - The company believes that future earnings power is substantially higher, allowing for debt repayment and investments in long-term growth [14] - Management acknowledged challenges in the agricultural economy but highlighted improvements in cost containment and operational efficiencies [18] Other Important Information - The company has remediated all material weaknesses identified during the 2024 audit, a significant achievement given the refinancing efforts [15] - Capital spending for 2025 was approximately $4 million, with expectations to increase spending in 2026 while remaining within the $5-$10 million range [19] Q&A Session Summary Question: What dragged on revenue and margin performance in Q4? - Management indicated that both international and domestic sales were affected, with lower Metam sales and demand for potato products in the U.S. and drought conditions in Australia impacting international sales [24][25] Question: How do the L.A. closure and headquarters relocation fit into long-term plans? - The rationalization of the L.A. facility and the headquarters move were not initially part of the transformation plan but became necessary as the company analyzed capacity utilization [27][28] Question: Are there any cash proceeds associated with the facility closures? - There are no immediate plans to sell assets from the L.A. facility, which will continue to operate at a lower scale, while the headquarters move is expected to save $500,000 annually [30][31] Question: Is it possible to achieve free cash flow positive in 2026? - Management expressed confidence that adjusted EBITDA projections, less interest and capital expenditures, would lead to a favorable cash flow position in 2026 [32] Question: Can you provide details on the $100 million revenue increase from new products? - New products are primarily coming from insecticides and herbicides, with a mid-term definition extending to around 2030-2031 [36][40]

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $28.2 million, down from $36.2 million in Q4 2024, impacted by user experience testing and traffic fluctuations [9] - Net income for Q4 2025 was $5.3 million (18.8% of revenue), compared to $6.9 million (19.1% of revenue) in the same period a year ago [9] - Full year revenue for 2025 was $134.8 million, an increase from $125.9 million in 2024, with non-advertising revenue increasing by over $21 million [10][11] - Adjusted EBITDA for 2025 improved to $51.5 million (38.2% of revenue) from $27 million (21.4% of revenue) in 2024 [11] Business Line Data and Key Metrics Changes - Advertising revenue represented 64% of total revenue in 2025, down from 74% in 2024, indicating a successful diversification strategy [10] - The company has focused on reducing reliance on external traffic sources, which has positively impacted non-advertising revenue streams [10] Market Data and Key Metrics Changes - The digital publishing landscape has been affected by recent search algorithm updates, leading to fluctuations in traffic patterns across the industry [5][6] - The company views these changes as a catalyst for innovation and growth, adapting its strategies accordingly [6] Company Strategy and Development Direction - The company is transitioning from a traditional publishing model to a brand, data, and IP company, leveraging first-party customer data to create a closed-loop ecosystem [13] - There is a focus on diversifying revenue streams, reducing debt, and maintaining a disciplined approach to capital management, including M&A activities [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to adapt to industry changes and generate positive cash flow in 2026 [12] - The company anticipates continued volatility in traffic but is focused on controlling its operations and maintaining a lean cost structure [17][18] Other Important Information - The company repaid $23.5 million in debt during 2025 and increased its cash balance by $6 million to $10.3 million [12] - The company plans to continue making 1-2 tuck-in media acquisitions per quarter to accelerate growth [23][24] Q&A Session Summary Question: Traffic volatility in Q1 2026 - Management noted that traffic has been volatile due to algorithm updates, with some properties performing well while others experience fluctuations [17] Question: Margin expectations for 2026 - Management expects to continue reducing reliance on advertising revenue, aiming for it to fall below 50%, which may positively impact margins [20] Question: Acquisition cadence and capital allocation - The company plans to maintain a cadence of 1-2 acquisitions per quarter while focusing on debt reduction and growth acceleration [23] Question: Share repurchase and refinancing timing - Management indicated that share repurchases are on hold until after refinancing, which is being approached with discipline to secure the right deal [26][29]

Financial Data and Key Metrics Changes - Net revenue increased by 2.2% year-over-year to $1.23 billion from $1.2 billion, driven by volume growth and pricing improvement in seafood and meat poultry [5][12] - Gross profit rose by 1.2% to $207.6 million, with gross profit margin slightly decreasing to 16.9% from 17.1% [12][14] - Adjusted EBITDA increased by 6.9% to $45 million compared to $42 million in the previous year [13][14] - Net loss attributable to HF Foods improved to $38.8 million from a loss of $48.5 million in 2024 [14] Business Line Data and Key Metrics Changes - Volume growth was noted in seafood and meat poultry, while other categories experienced volume decreases [12] - Distribution, selling, and administrative expenses increased by $3.7 million to $201.8 million, primarily due to higher depreciation and transformation expenses [13] Market Data and Key Metrics Changes - The company operates in a $50 billion addressable market, with HF Foods being the largest player in the Asian specialty space in the U.S. [11] - The company anticipates low single-digit growth for 2026, similar to 2025, for both adjusted EBITDA and gross profit [9] Company Strategy and Development Direction - The company is focused on a long-term transformation plan that includes sales operations consolidation, digital infrastructure upgrades, and facility renovations [5][6] - M&A remains a core pillar of the growth strategy, with a focus on expanding geographic footprint and enhancing product capabilities [10][11] - The company aims to leverage cross-selling opportunities and improve operational efficiency to drive organic growth [10][16] Management's Comments on Operating Environment and Future Outlook - Management acknowledged headwinds in the food service industry due to tariff pressures and lower foot traffic but expressed confidence in the long-term growth strategy [5][10] - The company is committed to disciplined execution and maintaining prudent capital deployment while pursuing tuck-in M&A opportunities [16][17] Other Important Information - The company completed its ERP implementation across all distribution centers, which is expected to enhance operational efficiencies [6][15] - Renovation of the Charlotte location is nearing completion, with operations expected to begin in Q2 2026 [7] Q&A Session Summary Question: Opportunities for Incremental Organic Growth - Management highlighted cross-selling opportunities in the Southeast, particularly with the new facility in Atlanta, and noted a ramp-up phase for volume [20][21] Question: February Traffic Year-over-Year Change - Management indicated that promotional campaigns initiated in late 2025 have positively impacted traffic and volume in Q1 2026 compared to 2025 [24][25] Question: IEEPA Tariffs and Refunds - Management stated it is too early to estimate potential refunds from tariffs and is assessing the situation closely [26][27]

Getty Images (NYSE:GETY) Q4 2025 Earnings call March 16, 2026 04:30 PM ET Speaker3Good afternoon, and welcome to Getty Images' fourth quarter and full year 2025 earnings conference call. Today's call is being recorded. We have allocated one hour for prepared remarks and Q&A. At this time, I would like to turn the conference over to Steven Kanner, Vice President of Investor Relations and Treasury at Getty Images. Thank you. You may begin.Speaker5Good afternoon, and thank you for joining our fourth quarter an ...

RF Industries (NasdaqGM:RFIL) Q1 2026 Earnings call March 16, 2026 04:30 PM ET Speaker1Greetings. Welcome to the RF Industries first quarter fiscal 2026 financial results conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference call is being recorded. Now I would like to turn th ...

Fourth Quarter and Full Year 2025 Financial Results March 16, 2026 Forward-Looking Statements This presentation contains forward-looking statements regarding Kyntra Bio's strategy, future plans and prospects, including statements regarding its commercial products and clinical programs and those of its partners Fortis and UCSF. These forward-looking statements include, but are not limited to, statements regarding the efficacy, safety, and potential clinical or commercial success of Kyntra Bio products and pr ...

Actual results, performance or achievements may differ materially, and potentially adversely, from any forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as forward-looking statements are based on estimates and assumptions that are inherently ...

FORWARD LOOKING STATEMENTS This presentation includes forward looking statements regarding PTC's future financial performance, strategic outlook and expectations, anticipated future operations, expected effects of strategic investments and initiatives, and share repurchase expectations. Because such statements deal with future events, actual results may differ materially from those projected in the forward-looking statements. Information about factors that could cause actual results to differ materially fro ...